Revenue Breakdown
Composition ()
No data
Revenue Streams
Tvardi Therapeutics Inc (TVRD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Other revenue , accounting for 51.5% of total sales, equivalent to $1.32M. Other significant revenue streams include Collaborative revenue and Clinical compound revenue. Understanding this composition is critical for investors evaluating how TVRD navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Comparative Benchmarking
In the context of the broader market, TVRD competes directly with industry leaders such as BTAI and TVGN. With a market capitalization of $31.80M, it holds a leading position in the sector. When comparing efficiency, TVRD's gross margin of N/A stands against BTAI's 87.50% and TVGN's N/A. Such benchmarking helps identify whether Tvardi Therapeutics Inc is trading at a premium or discount relative to its financial performance.
